Literature DB >> 21242015

Structural insights into Met receptor activation.

Hartmut H Niemann1.   

Abstract

The receptor tyrosine kinase Met plays a pivotal role in vertebrate development and tissue regeneration, its deregulation contributes to cancer. Met is also targeted during the infection by the facultative intracellular bacterium Listeria monocytogenes. The mechanistic basis for Met activation by its natural ligand hepatocyte growth factor/scatter factor (HGF/SF) is only beginning to be understood at a structural level. Crystal structures of Met in complex with L. monocytogenes InlB suggest that Met dimerization by this bacterial invasion protein is mediated by a dimer contact of the ligand. Here, I review the structural basis of Met activation by InlB and highlight parallels and differences to the physiological Met ligand HGF/SF and its splice variant NK1.
Copyright © 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21242015     DOI: 10.1016/j.ejcb.2010.11.014

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  17 in total

Review 1.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

2.  Biological roles of hepatocyte growth factor-Met signaling from genetically modified animals.

Authors:  Takashi Kato
Journal:  Biomed Rep       Date:  2017-10-18

Review 3.  Decorin: a guardian from the matrix.

Authors:  Thomas Neill; Liliana Schaefer; Renato V Iozzo
Journal:  Am J Pathol       Date:  2012-06-23       Impact factor: 4.307

4.  Fold and function of the InlB B-repeat.

Authors:  Maria Ebbes; Willem M Bleymüller; Mihaela Cernescu; Rolf Nölker; Bernd Brutschy; Hartmut H Niemann
Journal:  J Biol Chem       Date:  2011-02-23       Impact factor: 5.157

Review 5.  Targeted therapies in gastric cancer treatment: where we are and where we are going.

Authors:  Gianluca Tomasello; Michele Ghidini; Wanda Liguigli; Margherita Ratti; Laura Toppo; Rodolfo Passalacqua
Journal:  Invest New Drugs       Date:  2016-02-12       Impact factor: 3.850

6.  Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent.

Authors:  Mark Merchant; Xiaolei Ma; Henry R Maun; Zhong Zheng; Jing Peng; Mally Romero; Arthur Huang; Nai-ying Yang; Merry Nishimura; Joan Greve; Lydia Santell; Yu-Wen Zhang; Yanli Su; Dafna W Kaufman; Karen L Billeci; Elaine Mai; Barbara Moffat; Amy Lim; Eileen T Duenas; Heidi S Phillips; Hong Xiang; Judy C Young; George F Vande Woude; Mark S Dennis; Dorothea E Reilly; Ralph H Schwall; Melissa A Starovasnik; Robert A Lazarus; Daniel G Yansura
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-23       Impact factor: 11.205

7.  Lipopolysaccharide-induced phosphorylation of c-Met tyrosine residue 1003 regulates c-Met intracellular trafficking and lung epithelial barrier function.

Authors:  Yutong Zhao; Jing Zhao; Rachel K Mialki; Jianxin Wei; Ernst W Spannhake; Ravi Salgia; Viswanathan Natarajan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-26       Impact factor: 5.464

Review 8.  Dysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistance.

Authors:  Joseph J Sacco; Michael J Clague
Journal:  Transl Lung Cancer Res       Date:  2015-06

9.  Engineered variants of InlB with an additional leucine-rich repeat discriminate between physiologically relevant and packing contacts in crystal structures of the InlB:MET complex.

Authors:  Hartmut H Niemann; Ermanno Gherardi; Willem M Bleymüller; Dirk W Heinz
Journal:  Protein Sci       Date:  2012-09-17       Impact factor: 6.725

10.  Structural basis for the binding specificity of human Recepteur d'Origine Nantais (RON) receptor tyrosine kinase to macrophage-stimulating protein.

Authors:  Kinlin L Chao; Natalia V Gorlatova; Edward Eisenstein; Osnat Herzberg
Journal:  J Biol Chem       Date:  2014-09-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.